Edition:
India

SINOPHARM GROUP CO LTD (1099.HK)

1099.HK on Hong Kong Stock

30.65HKD
15 Dec 2017
Change (% chg)

HK$-0.10 (-0.33%)
Prev Close
HK$30.75
Open
HK$30.60
Day's High
HK$31.20
Day's Low
HK$30.50
Volume
6,573,510
Avg. Vol
5,714,836
52-wk High
HK$38.25
52-wk Low
HK$29.85

Latest Key Developments (Source: Significant Developments)

Virtual Incision Announces $18 Mln Series B Funding For Miniaturized Surgical Robots
Wednesday, 13 Dec 2017 

Dec 12 (Reuters) - Virtual Incision Corp::VIRTUAL INCISION ANNOUNCES $18 MILLION SERIES B FUNDING FOR MINIATURIZED SURGICAL ROBOTS.VIRTUAL INCISION CORPORATION - SERIES B FUNDING ROUND WAS CO-LED BY SINOPHARM CAPITAL & BLUESTEM CAPITAL.  Full Article

Sinopharm Group Says To Acquire Pudong Medicines And Herbs
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Sinopharm Group Co Ltd <1099.HK>::‍CO TO ACQUIRE 100% EQUITY INTEREST IN PUDONG MEDICINES AND HERBS FROM CHINA NATIONAL PHARMACEUTICAL GROUP CORP FOR RMB217.5 MILLION.  Full Article

China Vanguard You Champion says through unit enters into joint venture deal with Sino-TCM
Friday, 24 Nov 2017 

Nov 24 (Reuters) - China Vanguard You Champion Holdings Ltd <8156.HK> ::‍Co through its unit enters into a joint venture agreement with Sinopharm Traditional Chinese Medicine Co..  Full Article

Sinopharm Group says Li Zhiming proposes to cease to serve as president​
Tuesday, 21 Nov 2017 

Nov 21 (Reuters) - Sinopharm Group Co Ltd <1099.HK>::Li Zhiming proposed to cease to serve as president​.‍Li zhiming continues to serve as chairman of board​.‍Liu yong ceased to serve as vice president​.‍Board resolved to appoint liu yong as president of company​.  Full Article

Sinopharm Group posts ‍9-mnth profit attributable of RMB ‍3.66​ billion​
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Sinopharm Group Co Ltd <1099.HK>:9-month net profit attributable to equity holders of co RMB ‍3.66​ billion versus RMB3.60 billion.‍9-mnth total operating revenue RMB208.63 billion versus RMB193.10 billion ​.  Full Article

Sinopharm Group Co Ltd posts HY profit attributable rmb2.76 billion
Monday, 28 Aug 2017 

Aug 28 (Reuters) - Sinopharm Group Co Ltd <1099.HK>:HY profit attributable to owners of parent RMB2.76 billion versus RMB2.53 billion.HY revenue RMB 137.77 billion versus RMB 126.80 billion.  Full Article

Sinopharm posts half-year net profit of RMB 2.53 billion<1099.HK>
Monday, 22 Aug 2016 

Sinopharm Group Co Ltd <1099.HK>: Announcement on 2016 interim results <1099.HK> . Says no interim dividend was proposed for the six-month period ended 30 June 2016 . HY profit attributable to owners of the parent RMB 2.53 billion versus RMB 1.91 billion . Says HY revenue RMB 125.89 billion versus RMB 111.06 billion . The group has sufficient financial resources for ongoing operation in the foreseeable future" .  Full Article

Sinopharm updates on proposed adoption of restricted share incentive scheme<1099.HK>
Friday, 19 Aug 2016 

Sinopharm Group Co Ltd <1099.HK>: Announcement proposed adoption of restricted share incentive scheme <1099.HK> . Proposes to adopt the scheme to closely align the interests and benefits of and risks sharing among the shareholders, the company and the employees .  Full Article

Sinopharm updates on participation in pilot works of developing mixed-ownership economy<1099.HK>
Thursday, 18 Aug 2016 

Sinopharm Group Co Ltd <1099.HK>: Informed that CNPGC has obtained the "approval on implementation of share incentive scheme of Sinopharm Group Co Ltd" . Approval from the state-owned assets supervision and administration commission of the state council .  Full Article

Sinopharm Group proposes to dispose assets to Sinopharm (CNCM ltd)<1099.HK>
Wednesday, 20 Jul 2016 

Sinopharm Group Co Ltd <1099.HK>: Discloseable transactions proposed disposal of equity interests in certain subsidiaries held by the company to Sinopharm (CNCM Ltd) and connected transaction deemed disposal of equity interests in Sinopharm (CNCM Ltd) . Company, Sinopharm (CNCM Ltd), and the other minority shareholders entered into assets transfer agreements . Says aggregate consideration of approximately RMB5.37 billion . Company proposed to dispose the target assets to Sinopharm (CNCM ltd) . Deal will be satisfied by issuance of about 214.1 million consideration shares at RMB25.10 per consideration share by Sinopharm (CNCM Ltd) to co . On 20 July,sinopharm (CNCM Ltd) resolved that upon completion of transactions, shall issue 45.0199 million shares by way of non-public offer . Issuance of shares by way of non-public offer to raise proceeds of RMB1.13 billion in aggregate .  Full Article

BRIEF-Sinopharm Group posts ‍9-mnth profit attributable of RMB ‍3.66​ billion​

* 9-month net profit attributable to equity holders of co RMB ‍3.66​ billion versus RMB3.60 billion